Coya Therapeutics, Inc. (COYA) vs Immunic, Inc. (IMUX)

Coya Therapeutics, Inc. and Immunic, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Immunic, Inc. are of similar size ($127.2M and $121.5M). Immunic, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 13 metrics below, Coya Therapeutics, Inc. leads on 7 and Immunic, Inc. on 6.

Valuation

Metric COYA IMUX Biotechnology median
P/E n/m n/m 7.88
P/S 14.95 n/m 11.47
P/B 2.77 3.12 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 11.18 n/m 10.73
Earnings yield (20.94%) (46.84%) (28.84%)
Free cash flow yield (14.83%) (22.15%) (23.03%)

Profitability

Metric COYA IMUX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (138.17%) (57.72%)
Return on assets (53.66%) (101.15%) (49.22%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA IMUX Biotechnology median
Revenue growth (TTM) 108.35% — 5.64%
EPS growth (last fiscal year) (29.59%) 38.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 5.05 4.73
Net debt to EBITDA 2.08 0.15 0.96

Dividend

Metric COYA IMUX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric COYA IMUX Biotechnology median
Market cap 121.51m 127.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack